Bayer Agrees To Settle Some Contrast Dye Suits
Bayer AG has reached settlements with some plaintiffs in a slew of cases the German drugmaker faces over claims that its gadolinium-based injectable contrast agent Magnevist can cause serious health problems...To view the full article, register now.
Already a subscriber? Click here to view full article